Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I study of Plasmid DNA Drugs for Crohn's disease

Trial Profile

Phase I study of Plasmid DNA Drugs for Crohn's disease

Phase of Trial: Phase I

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Plasmid DNA therapeutics Alma Bio Therapeutics (Primary)
  • Indications Crohn's disease
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jul 2017 New trial record
    • 26 Jun 2017 According to an Alma Bio Therapeutics media release, the company plans to initiate this trial in the second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top